Gritstone Bio
(OTC) GRTS
Gritstone Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.70M
Net Income (TTM)
$133.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GRTS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gritstone Bio
Industry
Biotechnology
Sector
Health CareEmployees
231
CEO
Andrew R. Allen, MD, PhD
Website
www.gritstonebio.comHeadquarters
EmeryVille, CA 94608, US
GRTS Financials
Key Financial Metrics (TTM)
Gross Margin
-5%
Operating Margin
-116%
Net Income Margin
-104%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-78%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$6.26M
Operating Income
$154.63M
EBITDA
$126.86M
Operating Cash Flow
$121.65M
Capital Expenditure
$4.57M
Free Cash Flow
$126.22M
Cash & ST Invst.
$81.57M
Total Debt
$104.78M
Gritstone Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$57.00K
-85.8%
Gross Profit
$1.54M
-25.3%
Gross Margin
-27.07%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
231
N/A
Net Income
$23.40M
+33.6%
EBITDA
$20.49M
+26.4%
Quarterly Fundamentals
Net Cash
$45.51M
-337.7%
Accounts Receivable
$195.00K
-51.1%
Inventory
$0.00
N/A
Long Term Debt
$95.33M
+5.3%
Short Term Debt
$14.32M
+48.0%
Return on Assets
-77.90%
N/A
Return on Invested Capital
-1.03%
N/A
Free Cash Flow
$26.84M
+17.9%
Operating Cash Flow
$26.81M
+13.4%